Tranzyme Pharma Announces Exploration of Strategic Alternatives

Tranzyme Pharma Announces Exploration of Strategic Alternatives

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Feb. 8, 2013 (GLOBE NEWSWIRE) — Tranzyme, Inc. (Nasdaq:TZYM) announced today that its Board of Directors has made a determination to explore and evaluate strategic alternatives, … more

View todays social media effects on OCRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Ocera is hiring next, click here to view

Share this post